Literature DB >> 12628718

Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure.

Antonio Abbate1, Giuseppe G L Biondi-Zoccai, Rossana Bussani, Aldo Dobrina, Debora Camilot, Florinda Feroce, Raffaele Rossiello, Feliciano Baldi, Furio Silvestri, Luigi M Biasucci, Alfonso Baldi.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate a potential correlation between apoptotic rate (AR), post-infarction left ventricular (LV) remodeling, and clinical characteristics in subjects who died late (>or=10 days) after an acute myocardial infarction (AMI) with evidence of persistent occlusion of the infarct-related artery at autopsy.
BACKGROUND: Apoptosis contributes to myocardiocyte loss in cardiac disease and may have a pathophysiologic role in post-infarction LV remodeling.
METHODS: The AR was calculated at the site of infarction and in remote unaffected LV regions, using co-localization of in situ end labeling for deoxyribonucleic acid fragmentation and immunohistochemistry for caspase-3, in 14 subjects who died within two months after AMI. Correlation between AR and clinical characteristics such as age, site of AMI, transmural extension, multivessel coronary disease, and signs and/or symptoms of heart failure (HF), at the time of initial hospitalization for AMI or subsequently before death, was assessed using non-parametric statistical tests. Parameters of LV remodeling including diameters, free wall thickness, diameter-to-wall-thickness ratio, and mass were measured at gross examination at autopsy. Values are expressed as median (interquartile range).
RESULTS: Among clinical variables, early symptomatic post-infarction HF (9 cases, 64%) was associated with nearly fourfold increased AR at the site of infarction (26.2% [24.5% to 28.8%] vs. 6.4% [1.9% to 13.3%], p = 0.001). Moreover, AR both at the site of infarction and in unaffected regions was significantly correlated with parameters of progressive LV remodeling (p < 0.05).
CONCLUSIONS: Our data show that in patients dying >or=10 days after AMI, myocardial apoptosis is strongly associated with and may be a major determinant of unfavorable LV remodeling and early symptomatic post-infarction HF.

Entities:  

Mesh:

Year:  2003        PMID: 12628718     DOI: 10.1016/s0735-1097(02)02959-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  59 in total

1.  Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase.

Authors:  Stefano Toldo; Mariarosaria Boccellino; Barbara Rinaldi; Ignacio M Seropian; Eleonora Mezzaroma; Anna Severino; Lucio Quagliuolo; Benjamin W Van Tassell; Raffaele Marfella; Giuseppe Paolisso; Francesco Rossi; Ramesh Natarajan; Norbert Voelkel; Antonio Abbate; Filippo Crea; Alfonso Baldi
Journal:  Mol Med       Date:  2011-05-31       Impact factor: 6.354

2.  Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?

Authors:  A Abbate; D Santini; G G L Biondi-Zoccai; S Scarpa; F Vasaturo; G Liuzzo; R Bussani; F Silvestri; F Baldi; F Crea; L M Biasucci; A Baldi
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

Review 3.  Advances in fluorescence imaging of the cardiovascular system.

Authors:  Kiyuk Chang; Farouc Jaffer
Journal:  J Nucl Cardiol       Date:  2008 May-Jun       Impact factor: 5.952

4.  Immunohistochemical expression of activated caspase-3 in human myocardial infarction.

Authors:  Nina Zidar; Zvezdana Dolenc-Strazar; Jera Jeruc; Dusan Stajer
Journal:  Virchows Arch       Date:  2005-10-05       Impact factor: 4.064

5.  Increasing cardiac contractility after myocardial infarction exacerbates cardiac injury and pump dysfunction.

Authors:  Hongyu Zhang; Xiongwen Chen; Erhe Gao; Scott M MacDonnell; Wei Wang; Mikhail Kolpakov; Hiroyuki Nakayama; Xiaoying Zhang; Naser Jaleel; David M Harris; Yingxin Li; Mingxin Tang; Remus Berretta; Annarosa Leri; Jan Kajstura; Abdelkarim Sabri; Walter J Koch; Jeffery D Molkentin; Steven R Houser
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

Review 6.  Apoptosis and oncosis in acute coronary syndromes: assessment and implications.

Authors:  Bodh I Jugdutt; Halliday A Idikio
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

7.  Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury.

Authors:  Feifei Su; Valerie D Myers; Tijana Knezevic; JuFang Wang; Erhe Gao; Muniswamy Madesh; Farzaneh G Tahrir; Manish K Gupta; Jennifer Gordon; Joseph Rabinowitz; Frederick V Ramsey; Douglas G Tilley; Kamel Khalili; Joseph Y Cheung; Arthur M Feldman
Journal:  JCI Insight       Date:  2016-11-17

8.  Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.

Authors:  Soochan Bae; Sylvia S Singh; Hyeon Yu; Ji Yoo Lee; Byung Ryul Cho; Peter M Kang
Journal:  J Appl Physiol (1985)       Date:  2013-02-21

Review 9.  Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Exp Gerontol       Date:  2009-07-19       Impact factor: 4.032

10.  Comparative effects of a vasopeptidase inhibitor vs. an angiotensin converting enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure.

Authors:  Nathalie Lapointe; James N Tsoporis; Thomas G Parker; Charles Blais; Albert Adam; Dominique Rouleau; Graham Slaughter; Robert Clément; Christian E Deschepper; Jean L Rouleau
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.